The combined tablet preparation Alotendine (Amlodipine/Bisoprolol) is used for the treatment of elevated blood pressure (arterial hypertension) and chronic stable angina pectoris caused by certain reasons leading to a chronic lack of oxygen supply to the myocardium.
Active substances: Amlodipine and Bisoprolol.
Other ingredients: Colloidal anhydrous silicon dioxide, magnesium stearate, sodium starch glycolate (type A), microcrystalline cellulose.
The combined tablet preparation Alotendine (Amlodipine/Bisoprolol) is used for the treatment of elevated blood pressure (arterial hypertension) and chronic stable angina pectoris caused by certain reasons leading to a chronic lack of oxygen supply to the myocardium.
Consult your doctor or pharmacist before taking any medication.
There is no adequate clinical experience regarding the use of this medication in pregnant women; it should only be prescribed by a physician after careful individual assessment of the risk/benefit ratio. You should inform your doctor if you are pregnant or planning to become pregnant.
If prescribed during pregnancy, careful monitoring of the fetus and newborn is necessary.
Due to insufficient clinical experience, this medication is not recommended for use during breastfeeding.
Alotendine tablets may impair higher mental functions, especially at the beginning of treatment, when changing the treatment regimen, or when alcohol is consumed. Therefore, the decision about the ability to drive or operate machinery should be made individually by your doctor based on your condition and dosage.
Always follow your doctor’s instructions when taking Alotendine. If you are unsure about the correct use of this medication, consult your doctor or pharmacist.
The usual dose is one tablet of a certain dosage. It is recommended to take Alotendine tablets in the morning, independently of meals, with a small amount of water, without chewing.
Based on treatment response, your doctor may increase the starting dose or combine it with other dosages.
Generally, no dose adjustment is required in patients with mild to moderate renal impairment.
In cases of severe liver or kidney disease, dose adjustment may be necessary.
Do not stop taking the medication without a valid reason or without consulting your doctor.
Dose adjustment is not required in elderly patients.
Use in children is not recommended, as the safety and efficacy of this medication in this patient group have not been established.
If you believe the therapeutic effect of Alotendine tablets is excessive or insufficient, consult your doctor or pharmacist.
Store this medication in its original packaging at a temperature not exceeding 30°C.
Keep out of reach of children.
Do not use Alotendine after the expiry date indicated on the packaging.
